Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • SeaStar Medical Holding's Total Current Liabilities fell 3874.66% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 3874.66%. This contributed to the annual value of $6.8 million for FY2024, which is 4756.25% down from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Total Current Liabilities is $4.1 million, which was down 3874.66% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Total Current Liabilities ranged from a high of $21.3 million in Q1 2023 and a low of $4.1 million during Q3 2025
  • Over the past 3 years, SeaStar Medical Holding's median Total Current Liabilities value was $9.6 million (recorded in 2024), while the average stood at $10.1 million.
  • Per our database at Business Quant, SeaStar Medical Holding's Total Current Liabilities tumbled by 5465.53% in 2024 and then crashed by 2711.44% in 2025.
  • Over the past 3 years, SeaStar Medical Holding's Total Current Liabilities (Quarter) stood at $13.0 million in 2023, then crashed by 47.56% to $6.8 million in 2024, then tumbled by 40.56% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $5.0 million for Q2 2025, and $7.0 million during Q1 2025.